Sodium citrate
- Generic Name
- Sodium citrate
- Brand Names
- As 3, Bss, Bss Ophthalmic Solution, Cpda-1 Blood Collection System, Dalmacol, EnLyte, Intersol, Leukotrap, Nauzene, Oracit, Tricitrasol
- Drug Type
- Small Molecule
- Chemical Formula
- C6H5Na3O7
- CAS Number
- 68-04-2
- Unique Ingredient Identifier
- RS7A450LGA
- Background
Sodium citrate is the sodium salt of citric acid. It is white, crystalline powder or white, granular crystals, slightly deliquescent in moist air, freely soluble in water,
practically insoluble in alcohol. Like citric acid, it has a sour taste.
...
- Indication
Used as an anticoagulant during plasmophoresis as well as a neutralizing agent in the treatment of upset stomach and acidic urine .
- Associated Conditions
- Acidosis, Allergic Reaction, Allergic cough, Asthma, Asthma Chronic, Cough, Common Cold, Cough, Coughing caused by Bronchitis, Dehydration, Gout, Heartburn, Metabolic Acidosis, Phlegm
- Associated Therapies
- Airway secretion clearance therapy, Oral rehydration therapy, Plasmapheresis, Urine alkalinization therapy, Fluid and electrolyte maintenance therapy, Irrigation during surgical procedures, Irrigation of the ocular surface therapy
Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
- First Posted Date
- 2024-01-12
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 60
- Registration Number
- NCT06204432
- Locations
- 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation
- Conditions
- Interventions
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 15
- Registration Number
- NCT05191290
- Locations
- 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
- Conditions
- Interventions
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 40
- Registration Number
- NCT05067270
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung, Neuss, Nordrhein-Westfalen, Germany
🇩🇪Profil Mainz, Mainz, Germany
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2020-02-26
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 30
- Registration Number
- NCT04284657
- Locations
- 🇺🇸
Keck School of Medicine of University of Southern California, Los Angeles, California, United States
Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)
- Conditions
- Interventions
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 2
- Registration Number
- NCT00968565
- Locations
- 🇺🇸
Vanderbilt Children's Hospital, Nashville, Tennessee, United States
Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac Defects
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 150
- Registration Number
- NCT00004361
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.